Literature DB >> 11208460

Helicobacter pylori, gastrin and cyclooxygenase-2 in lung cancer.

W Gocyk1, T Nikliński, H Olechnowicz, A Duda, W Bielański, P C Konturek, S J Konturek.   

Abstract

INTRODUCTION: Tumors arising in the lungs are in over 90% bronchogenic carcinomas that have been attributed predominantly to tobacco smoking, asbestos or air pollution but little is known about endogenous factors that could facilitate their development and invasiveness. The lungs originate embryologically from the same endoderm cells which form the epithelia lining the digestive tract, where gastrin is the major proliferative stimulus. AIMS: Since lung cancer patients were recruited mostly among smokers, who also have been found to exhibit significantly higher infection rate of Helicobacter pylori (HP) infection than non-smokers and, as since the HP-infected subjects show enhanced plasma levels of gastrin, we decided 1) to compare the seroprevalence of HP and the expression of its cytotoxin, CagA, in lung cancer patients with those in the age- and gender-matched controls without cancer: 2) to determine the gene expression for gastrin and its receptors (CCKB-R) in lung cancer, 3) to assess the gastrin levels in plasma bronchial lavage and in tumor tissue and 4) to examine the expression of cyclooxygenase (COX)-1 and COX-2 in cancer tissue resection margin and intact bronchial mucosa.
MATERIAL AND METHODS: The trial material included 50 patients with lung carcinoma and 100 age- and gender-matched controls. Anti-HP and anti-CagA IgG seroprevalence was estimated by specific antisera using ELISA tests. Gene expression of gastrin, CCKB-R, COX-1 and COX-2 was examined using RT-PCR, while gastrin was measured by specific RIA.
RESULTS: The seroprevalence of HP, especially that expressing CagA, is significantly higher in lung cancers than in healthy controls. Both gastrin and CCKB-R mRNA were detected in the cancer tissue and at the resection margin and similarly COX-2 mRNA was expressed in most cancers and resection margin but not in bronchial mucosa where only COX-1 was found. The lung cancer tissue and resection margin contained many folds larger amounts of immunoreactive gastrin than intact bronchial mucosa.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11208460

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  14 in total

Review 1.  Role of bacteria in oncogenesis.

Authors:  Alicia H Chang; Julie Parsonnet
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

2.  Diagnosis of Helicobacter pylori infection and diseases associated with Helicobacter pylori by Helicobacter pylori outer membrane proteins.

Authors:  Zheng Jiang; Ai-Long Huang; Xiao-Hong Tao; Pi-Long Wang
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

3.  Recombinant Helicobacter pylori catalase.

Authors:  Yang Bai; Ya-Li Zhang; Jian-Feng Jin; Ji-De Wang; Zhao-Shan Zhang; Dian-Yuan Zhou
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

4.  Associations of lung cancer risk with biomarkers of Helicobacter pylori infection.

Authors:  Hyung-Suk Yoon; Xiao-Ou Shu; Hui Cai; Wei Zheng; Jie Wu; Wanqing Wen; Regina Courtney; Chris Shidal; Tim Waterboer; William J Blot; Qiuyin Cai
Journal:  Carcinogenesis       Date:  2022-06-27       Impact factor: 4.741

5.  Helicobacter pylori seroprevalence in patients with lung cancer.

Authors:  Nikiphoros Philippou; Panagiotis Koursarakos; Evgenia Anastasakou; Vasiliki Krietsepi; Stavroula Mavrea; Anastasios Roussos; Dionissia Alepopoulou; Irineos Iliopoulos
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

6.  Construction and characterization of bivalent vaccine candidate expressing HspA and M(r)18,000 OMP from Helicobacter pylori.

Authors:  Zheng Jiang; Ai-Long Huang; Xiao-Hong Tao; Pi-Long Wang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

7.  H pylori seroprevalence in patients with lung cancer.

Authors:  Katayoon Najafizadeh; Sayeed Falah Tafti; Masoud Shiehmorteza; Masoud Saloor; Masoud Jamali
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

8.  Association between Helicobacter pylori and mortality in the NHANES III study.

Authors:  Yu Chen; Stephanie Segers; Martin J Blaser
Journal:  Gut       Date:  2013-01-08       Impact factor: 23.059

Review 9.  Helicobacter pylori infection and respiratory diseases: a review.

Authors:  Anastasios Roussos; Nikiforos Philippou; Konstantinos I Gourgoulianis
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

10.  Helicobacter pylori seropositivity and risk of lung cancer.

Authors:  Jill Koshiol; Roberto Flores; Tram K Lam; Philip R Taylor; Stephanie J Weinstein; Jarmo Virtamo; Demetrius Albanes; Guillermo Perez-Perez; Neil E Caporaso; Martin J Blaser
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.